Attached files

[Logo]
Dynasil



Contacts:
Patty Kehe
Dynasil Corporation of America
Phone: 617.668.6855
Email: pkehe@dynasilcorp.com

David Calusdian
Executive Vice President and Partner
Sharon Merrill
617.542.5300
DYSL@InvestorRelations.com

  Dynasil Announces Promotion of Dr. Kanai S. Shah to Lead
       RMD, Inc. Subsidiary Starting in January, 2012

Watertown, Mass., October 3, 2011 - Dynasil Corporation of
America (NASDAQ: DYSL) and Gerald Entine, Ph.D., Founder and
President of the Company's wholly owned subsidiary,
Radiation Monitoring Devices, Inc. (RMD), announced the
promotion of  Kanai S. Shah, Ph.D., RMD's Vice President of
Research and the leader of the Material Science Group, to
President of  RMD, Inc. effective January 1, 2012.  Dr.
Entine, 68, will continue as a member of Dynasil's board of
directors and beginning in January will assume the role of
President Emeritus of RMD.

Stated Dr. Entine, "What could be more rewarding than
watching your long-time friend and collaborator take over the
institution you created.  I am most pleased that Kanai has
accepted this challenge and look forward to watching RMD
continue to prosper under his leadership."

Dr. Shah, 50, joined RMD in 1985 as a Staff Scientist.
Initially he was involved in a program aimed at stabilizing
low energy X-ray detectors for NASA, and then managed a
variety of research projects focused on semiconductor and
scintillator detectors. He worked briefly for Canberra
Industries in the early 1990s, investigating high-purity
germanium gamma-ray detectors and high resolution, low noise
silicon X-ray detectors.  He rejoined RMD as a Senior
Scientist in 1993, advancing to Director of Research in 2002
and Vice President of Research in 2009. He has been
responsible for new semiconductor and scintillator
development at RMD for more than 10 years and is widely
regarded as a leading expert in this field.




Dr. Shah received a bachelor's degree in Chemical Engineering
from India's Gujarat University in 1983, a master's degree in
Chemical Engineering from the University of Lowell (now the
University of Massachusetts Lowell) in 1987 and a Ph.D. in
Applied Physics from the Delft University of Technology in
2010. His doctoral research focused on investigation of new
scintillator and photodetection technologies for use in
medical imaging, particularly positron emission tomography.
Dr. Shah has been awarded five U.S. patents and has authored
more than 80 technical papers.  In 2007, he received a
performance award from the Department of Homeland Security's
Domestic Nuclear Detection Office.

"Kanai combines the scientific knowledge and customer
engagement and management skills that will be essential in
developing new technologies, commercializing new products and
expanding our business development initiatives to additional
government agencies and institutions.  There is simply no one
better or more qualified to lead RMD into the future," said
Dynasil President Steven Ruggieri.

"Since founding RMD in 1974, Dr. Entine has guided the
business to operational success through a commitment to
developing innovative products and technologies for
specialized applications, including radiation detection and
nuclear instrumentation," said Dynasil Chairman Peter Sulick.
"In the three years since RMD became the Research Division of
Dynasil, under his leadership, the division's annual revenues
and profits have increased significantly, it has transferred
a new neutron detector technology to the recently acquired
Hilger Crystal division, it has earned the 2011 Department of
Homeland Security Small Business Achievement Award and it has
been issued thirteen new patents. His role as President
Emeritus will afford him an opportunity to enjoy some well-
deserved time off while still assisting in selected
scientific projects.  Additionally, Dr. Entine will continue
as a director of Dynasil Corporation of America."

About Dynasil
Dynasil Corporation of America (NASDAQ: DYSL) develops and
manufactures detection and analysis technology, precision
instruments and optical components for the homeland security,
industrial and biomedical markets.  Combining world-class
technology with expertise in research and materials science,
Dynasil is commercializing products including dual-mode
radiation detection solutions for Homeland Security and
commercial applications, probes for medical imaging and
sensors for non-destructive testing.  Through its Dynasil
Biomedical unit, the Company is developing early stage
opportunities for the biomedical technology area.  Dynasil
has an impressive and growing portfolio of issued and pending
U.S. patents.  The Company is based in Watertown,
Massachusetts, with additional operations in Mass., Minn.,
NY, NJ and the United Kingdom. More information about the
Company is available at www.dynasilcorp.com.





Safe Harbor
This news release may contain forward-looking statements
pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act.  These statements involve a
number of risks and uncertainties.  Future results of
operations, projections, and expectations, which may relate
to this release, involve certain risks and uncertainties that
could cause actual results to differ materially from the
forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited
to, the factors detailed in the Company's Annual Report on
Form 10-K, Quarterly Reports on Form 10-Q, as well as in the
Company's other Securities and Exchange Commission filings.